Abstract: Disclosed is an organic electroluminescent material and device. The organic electroluminescent material is a novel metal complex that comprises a ligand having a fluorene structure and a ligand having a dibenzofuran, dibenzothiophene, or dibenzoselenophene structure, and has a general formula of M(La)m(Lb)n(Lc)q, where the ligand La has a structure represented by Formula IA, the ligand Lb has a structure represented by Formula IB, and the ligand Lc is a monoanionic bidentate ligand. The metal complex may be used as the light-emitting material in the organic electroluminescent device. These novel compounds can greatly improve the device efficiency and provide better device performance. Further provided are an electroluminescent device and a compound formulation.

Abstract: The present disclosure relates to rotigotine behenate, methods for preparing the same and use of the same for treating diseases associated with dopamine receptor. The rotigotine behenate, the structure of which is shown below, is capable of reducing fluctuation in blood drug concentrations, improving the bioavailability of the drug in vivo, and achieving smooth and extended release of rotigotine.

Abstract: Embodiments of this application provide a communication method and apparatus, a computer-readable medium, and an electronic device. The communication method includes: obtaining a total latency tolerance of uplink (UL) transmission and downlink (DL) transmission of a target service; generating a transmission latency indication message for the target service according to the total latency tolerance, the transmission latency indication message including quality of service (QoS) flow indication information of the UL transmission of the target service and QoS flow indication information of the DL transmission of the target service; and configuring the transmission latency indication message for a radio access network (RAN) entity, so as to enable the RAN entity to monitor a transmission latency of the target service according to the transmission latency indication message.

Abstract: A seed coating agent for preventing and treating a wheat rot disease is provided. The seed coating agent includes a fungicide and a seed priming and elicitor. The fungicide includes silthiopham and coumoxystrobin. The seed priming and elicitor includes salicylic acid and compound sodium nitrophenolate. The weight percentage of each components is 1%-60% of the fungicide, 0.0005%-0.05% of salicylic acid, and 0.001%-0.1% of compound sodium nitrophenolate. The seed coating agent has a good effect of promoting seed germination and strengthening seedlings on wheat seeds. Both silthiopham and coumoxystrobin are of low toxicity, and are safe for humans, animals, beneficial organisms, and the environment.

Abstract: Embodiments of the disclosure disclose a network slice processing method, system, and device, and a storage medium. The method is applicable to a network management system, and includes: virtualizing functions of a mobile communication network to obtain a plurality of isolated logical subnetworks, and using each logical subnetwork as a network slice; generating a slice-level quality of service (QoS) parameter for each network slice, the slice-level QoS parameter being used by the network management system to instruct a slice processing device to control a first resource corresponding to the network slice; and transmitting the slice-level QoS parameter to the slice processing device.

Abstract: A temperature demodulation method oriented toward a distributed fiber Raman temperature sensing system, the method comprising the following steps: step 1 of constructing a high-precision temperature detection device oriented towards a distributed fiber Raman sensing system; step 2 of performing signal processing with respect to Stokes light and anti-Stokes light at a calibration stage; step 3 of performing signal processing with respect to Stokes light and the anti-Stokes light at a measurement stage; and step 4 of obtaining a high-precision temperature demodulation technique oriented toward the distributed fiber Raman sensor. The method is used to effectively resolve the issue of low temperature measuring accuracy caused by Rayleigh crosstalk in existing distributed fiber Raman temperature measurement systems, and temperature measurement accuracy thereof is expected to fall within ±0.1° C. The method is applicable to distributed fiber Raman temperature measurement systems.

Abstract: A device includes an enclosure and logic. The enclosure includes a plurality of capacitive touch sensor arrays disposed at least on two of a top side, a bottom side, a left side, a right side, a front side, and a back side of the device. The enclosure also includes a first display on the front side of the device. The logic receives touch interaction information from the plurality of capacitive touch sensor arrays and initiates an action based at least in part on the touch interaction information.

Abstract: A flexible display panel and a display device. The flexible display panel includes a flexible substrate having a display area and a non-display area surrounding the display area; the display panel also includes at least one blocking wall located on the non-display area and surrounding the display area, a light-emitting structure located on the display area, and a packaging film covering the light-emitting structure and the blocking wall; the flexible display panel has a bending area and a non-bending area, and the thickness of the parts, in the bending area, of the blocking wall is not equal to the thickness of the parts, in the non-bending area, of the blocking wall.

Abstract: The present invention relates to a pharmaceutical composition containing ilaprazole or a salt thereof, and a preparation method therefor. The pharmaceutical composition contains or consists of ilaprazole or a salt thereof, and a ilaprazole derivative, wherein the amount of the ilaprazole derivative in the pharmaceutical composition is not higher than 1.3 wt % (less than or equal to 1.3 wt %). The composition can be used for treating peptic ulcer bleeding and stress ulcer and preventing upper gastrointestinal hemorrhage caused by severe diseases.

Abstract: An event processing method, a device, and a system are disclosed in embodiments of this disclosure, to facilitate an application program adjusting a parameter configuration policy according to a radio signal strength of a UE. The event processing method according to an embodiment includes: generating a location report request, the location report request being used for requesting a deferred location report based on a radio signal strength of a user equipment (UE) and indicating a triggering event for triggering the deferred location report; transmitting the location report request to the UE, the location report request triggering the UE to determine whether the triggering event occurs according to the radio signal strength of the UE; and obtaining event reporting information transmitted by the UE to the location application device in response to the triggering event occurring.

Abstract: The present invention provides compounds of formula V: or pharmaceutically acceptable salts thereof, useful as inhibitors of MK2 kinases, compositions thereof, and methods of using the same.

Abstract: A method for configuring a set of hardware accelerators to process a CNN. In an embodiment, the method includes one or more computer processors determining a set of parameters related to a feature map to analyze at a respective layer of the CNN, the set of parameters include quantization value and respective values that describe a shape of the feature map. The method further includes configuring a set of hardware accelerators for the respective layer of the CNN. The method further includes receiving a portion of the feature map to the configured set of hardware accelerators for the respective layer of the CNN, wherein the received portion of the feature map includes a group of sequential data slices. The method further includes analyzing the group of sequential data slices among the configured set of hardware accelerators.

Abstract: An aqueous dispersion of multistage polymer particles comprising a specific oligomer prepared from polymerization of monomers comprising an alkoxylated (meth)acrylate providing aqueous coating compositions with both good flow-and-leveling property and extended open time.

Abstract: Disclosed is an energy-saving bidirectional ship lift by gravity balancing, including: a ship lift body. A first support is provided in a middle of the ship lift body. A second support is provided at a side of the first support. A third support is provided at the other side of the first support. A space between the second support and the first support forms a first shaft. A space between the first support and the third support forms a second shaft. A first ship-carrying chamber and a second ship-carrying chamber are respectively provided in the first shaft and the second shaft to allow two ships to be transported at the same time. An entry water tank and an exit water tank are provided at two sides of each ship-carrying chamber to adjust the weight of the two ship-carrying chambers.

Abstract: Readout circuit and magnetic memory are provided. The readout circuit includes a first charging capacitor with one end grounded and another end coupled to an output of a data unit; a first pre-charge module for charging the first charging capacitor; a first discharge control module for controlling a magnitude of a data voltage; a second charging capacitor with one end grounded and another end coupled to an output of a reference unit; a second pre-charge module for charging the second charging capacitor; a second discharge control module for controlling a magnitude of a reference voltage; and a sense amplifier for outputting readout signals.

Abstract: The present disclosure provides a method and a device for identifying clues about medical adverse events, electronic equipment, and a memory medium. This method includes the steps of: acquiring diagnosis and treatment information on a patient; acquiring a knowledge base of clinical pathway medical orders or a keyword library of medical adverse events corresponding to the diagnosis and treatment information; and determining whether a clue about medical adverse events exists in the diagnosis and treatment information based on the knowledge base of clinical pathway medical orders or the keyword library of medical adverse events.

Abstract: Described herein are tetrahydro-pyrido[3,4-b]indol-1-yl compounds with estrogen receptor modulation activity or function having the Formula I structure: and stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, and with the substituents and structural features described herein. Also described are pharmaceutical compositions and medicaments that include the Formula I compounds, as well as methods of using such estrogen receptor modulators, alone and in combination with other therapeutic agents, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.

Abstract: The present disclosure relates to micro-LED chips, methods for manufacturing the same, and display devices. The micro-LED chip includes: a driving backplane including at least one first electrode, a groove being provided above the first electrode, and the first electrode being located at a bottom of the groove; the groove being filled with a conductive material, and the conductive material being obtained by curing a corresponding conductive ink; and a light emitting chip including at least one second electrode; and the first electrode is connected to the second electrode through the conductive material.

Abstract: A battery system includes a rechargeable energy storage system (RESS) having battery cells, and a battery controller network configured to execute two-level logic to detect a thermal runaway condition. The network includes RES S-embedded cell monitoring units (CMUs) electrically connected to a respective cell group, and measuring and wirelessly transmitting cell data. A battery control module (BCM) is in communication with the CMUs. Thermal runaway sensors are mounted on the CMUs and/or the BCM. A master controller connected to the BCM includes a thermal runaway detection algorithm configured to detect a thermal runaway condition occurring within the RESS. The BCM uses data from the CMUs and thermal runaway sensors to execute first logic level which determines when to wake up the master controller. The master controller, in response to receipt of a wakeup signal, executes a second logic level to execute the algorithm.